DALAZATIDE, AN INHIBITOR OF THE KV1.3 CHANNEL ON ACTIVATED EFFECTOR MEMORY T CELLS, HAS IMMUNOTHERAPY POTENTIAL IN SYSTEMIC LUPUS ERYTHEMATOSUS

被引：1
|
作者：
Stevens, A. M. [1 ,2 ]
Yuasa, M. [2 ]
Peckham, D. [3 ]
Olsen, C.
Iadonato, S. P. [3 ,4 ]
Probst, P. [3 ]
机构：
[1] Univ Washington, Pediatr, Seattle, WA 98195 USA
[2] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA USA
[3] Kineta Inc, Seattle, WA USA
[4] KPI Therapeut Inc, Seattle, WA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.5866
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0285
引用
收藏
页码：290 / 290
页数：1
相关论文
共 50 条
  • [1] Dalazatide, an Inhibitor of the Kv1.3 Channel on Chronically Activated Effector Memory T Cells, Has Immunotherapy Potential Against Sporadic Inclusion Body Myositis
    Mozaffar, Tahseen
    Wencel, Marie
    Goyal, Namita A.
    Phillips, Craig W.
    Olsen, Chelsea
    ANNALS OF NEUROLOGY, 2017, 82 : S195 - S196
  • [2] Dalazatide (ShK-186), a Kv1.3 Channel Inhibitor That Targets Effector Memory T Cells: Ex Vivo Studies in Pediatric Systemic Lupus Erythematosus
    Yuasa, Megan
    Peckham, David
    Stevens, Anne M.
    Iadonato, Shawn P.
    Munoz-Elias, Ernesto J.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [3] Kv1.3 expression on effector memory T cells in sporadic inclusion body myositis: potential for targeted immunotherapy with dalazatide
    Mozaffar, T.
    Wencel, M.
    Goyal, N.
    Philips, C.
    Olsen, C.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S158 - S158
  • [4] Targeting effector memory T-cells with Kv1.3 blockers
    Wulff, Heike
    Pennington, Michael
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2007, 10 (04) : 438 - 445
  • [5] Altered dynamics of kv1.3 channel compartmentalization in the immunological synapse in systemic lupus erythematosus
    Nicolaou, Stella A.
    Szigligeti, Peter
    Neumeier, Lisa
    Lee, Susan Molleran
    Duncan, Heather J.
    Kant, Shashi K.
    Mongey, Anne Barbara
    Filipovich, Alexandra H.
    Conforti, Laura
    JOURNAL OF IMMUNOLOGY, 2007, 179 (01): : 346 - 356
  • [6] Altered dynamics of Kv1.3 channel compartmentalization in the immunological synapse in systemic lupus erythematosus.
    Nicolaou, Stella
    Szigligeti, Peter
    Duncan, Heather
    Neumeier, Lisa
    Lee, Susan Molleran
    Kant, Shashi
    Filipovich, Alexandra
    Conforti, Laura
    CLINICAL IMMUNOLOGY, 2006, 119 : S68 - S68
  • [7] Imaging Kv1.3 Expressing Memory T Cells as a Marker of Immunotherapy Response
    Goggi, Julian L.
    Khanapur, Shivashankar
    Ramasamy, Boominathan
    Hartimath, Siddesh V.
    Rong, Tang Jun
    Cheng, Peter
    Tan, Yun Xuan
    Yeo, Xin Yi
    Jung, Sangyong
    Goay, Stephanie Shee Min
    Ong, Seow Theng
    Hwang, You Yi
    Chandy, K. George
    Robins, Edward G.
    CANCERS, 2022, 14 (05)
  • [8] Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases
    Beeton, C
    Pennington, MW
    Wulff, H
    Singh, S
    Nugent, D
    Crossley, G
    Khaytin, I
    Calabresi, PA
    Chen, CY
    Gutman, GA
    Chandy, KG
    MOLECULAR PHARMACOLOGY, 2005, 67 (04) : 1369 - 1381
  • [9] Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for the therapy of autoimmune diseases
    Becton, C
    Pennington, MW
    Singh, S
    Nugent, D
    Crossley, G
    Khaytin, I
    Calabresi, P
    Chandy, KG
    FASEB JOURNAL, 2005, 19 (04): : A344 - A345
  • [10] Glutamate levels and activity of the T cell voltage-gated potassium Kv1.3 channel in patients with systemic lupus erythematosus
    Poulopoulou, C.
    Papadopoulou-Daifoti, Z.
    Hatzimanolis, A.
    Fragiadaki, K.
    Polissidis, A.
    Anderzanova, E.
    Davaki, P.
    Katsiari, C. G.
    Sfikakis, P. P.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (05): : 1445 - 1450
12345